stockrow
Monday 9 November 2026
Export IVF’s income statement to Excel — free account
INVO Fertility, Inc
IVFINVO Fertility, Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.8 million, up 4.74% from fiscal 2024.
- Revenue
- +16.7%
- EPS
- +100.1%
- Free cash flow
- +35.1%
- Total debt
- −50.7%
Quarter to June 2026, against a year earlier
2.14
0.11
+5.42%
Follow IVF
Alert me
INVO Fertility, Inc (IVF) P/E ratio
INVO Fertility, Inc has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 41 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | n/m |
| ICCM IceCure Medical Ltd. compare | n/m |
| VVOS Vivos Therapeutics, Inc. compare | n/m |
| BJDX Bluejay Diagnostics, Inc. compare | n/m |
| CODX Co-Diagnostics, Inc. compare | n/m |
| AMIX Autonomix Medical, Inc. compare | n/m |
| AIDX 20/20 Biolabs Inc. compare | n/m |
| IVF INVO Fertility, Inc | n/m |
| NUWE Nuwellis, Inc. compare | n/m |
| Medical Devices industry median | 24.9× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)